Steve Jenner
About Steve Jenner
Steve Jenner is the Vice President of Marketing & Operations at Neurelis, with over 20 years of experience in the pharmaceutical and biotechnology industry, specializing in neurology, pain, glaucoma, and dermatology markets.
Steve Jenner - Vice President of Marketing & Operations at Neurelis
Steve Jenner serves as the Vice President of Marketing & Operations at Neurelis, a position he has held since early 2019. With over 20 years of experience in the pharmaceutical and biotechnology industry, Jenner brings deep expertise to his role, particularly in the neurology, pain, glaucoma, and dermatology markets.
Steve Jenner's Experience in Neurology, Pain, Glaucoma, and Dermatology Markets
Steve Jenner has significant experience in several specialized markets including neurology, pain, glaucoma, and dermatology. His career spans over two decades, during which he has contributed to product development and commercialization in these fields. Jenner's roles have consistently involved strategic marketing, operational leadership, and business development.
Steve Jenner's Role at Zogenix
Before joining Neurelis, Steve Jenner was the Vice President of Commercial for the U.S. Market at Zogenix. In this role, he led the commercialization of several product launches. Jenner also acted as the commercial point person for all business development initiatives and was involved in the initial buildout of the rare disease business unit for the U.S. Market. His leadership contributed significantly to Zogenix’s market expansion and strategic initiatives.
Steve Jenner's Career at MedAccess Communications and Other Pharmaceutical Companies
Steve Jenner has held several key roles throughout his career, including serving as the Senior Vice President of Client Services at MedAccess Communications. Additionally, he has held marketing and product management leadership positions at notable pharmaceutical companies such as Valeant Pharmaceuticals International, Allergan Pharmaceuticals, and Elan Pharmaceuticals, Inc. His diverse background has equipped him with a broad perspective on the pharmaceutical industry.